Order results by:
Issue | Title | |
Vol 11, No 2 (2015) | LOW SODIUM DIET: PROS AND CONS | Abstract similar documents |
O. M. Drapkina, R. N. Shepel' | ||
"... Currently, there is rather contradictory evidence on the effectiveness of a low sodium diet ..." | ||
Vol 12, No 6 (2016) | ROLE OF NON-DRUG THERAPIES OF METABOLIC SYNDROME: CHALLENGES AND PROSPECTS | Abstract similar documents |
S. N. Strelkova, K. V. Ovsyannicov, N. I. Utkina | ||
Vol 16, No 6 (2020) | Healthy Diet: New Rations for Individual Use | Abstract similar documents |
O. B. Shvabskaia, N. S. Karamnova, O. V. Izmailova | ||
"... , is the basis of the healthy diet. Among healthy nutritious rations, there are those that have developed ..." | ||
Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
"... ), myocardial hypertrophy, chronic heart failure (CHF) and atrial fibrillation (AF). Diet therapy ..." | ||
Vol 18, No 6 (2022) | Healthy Eating in Population Models of Nutrition: Asian Diet Style Summary | Abstract similar documents |
O. B. Shvabskaia, N. S. Karamnova, O. V. Izmailova, O. M. Drapkina | ||
"... researchers rightly associate with the nature of nutrition existing in these territories. The Japanese diet ..." | ||
Vol 16, No 2 (2020) | Mediterranean Diet: Origin History, Main Components, Evidence of Benefits and Feasibility to Adapt to the Russian Reality | Abstract similar documents |
D. U. Akasheva, O. M. Drapkina | ||
"... An unhealthy diet takes the lead in the concept of cardiovascular risk factors. It contributes ..." | ||
Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
Vol 20, No 6 (2024) | Rational approaches to the treatment of patients with overweight and obesity: a cardiologist’s view | Abstract similar documents |
S. V. Miklishanskaya, N. A. Mazur | ||
"... on the available data, the Mediterranean diet, brisk walking, and metformin, despite a slower and more moderate ..." | ||
Vol 16, No 6 (2020) | Population-based Cardiovascular Disease Prevention Measures Aimed at Reducing Salt Intake: Analysis of International Strategies and Prospects for Implementation in the Russian Federation | Abstract similar documents |
Yu. A. Balanova, A. V. Kontsevaya, N. S. Karamnova, D. K. Mukaneeva, O. M. Drapkina | ||
"... intake are: determining population salt consumption, identifying sources of salt in the diet, monitoring ..." | ||
Vol 20, No 4 (2024) | Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension | Abstract similar documents |
O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova | ||
"... is played by an increase of sodium reabsorption in the kidneys, associated with excessive activity ..." | ||
Vol 17, No 6 (2021) | Hyperuricemia: Features of the Diet | Abstract similar documents |
O. B. Shvabskaia, O. V. Izmailova, N. S. Karamnova, O. M. Drapkina | ||
"... , and modifiable factors include diet and lifestyle. Nutritional unbalances, increased life expectancy, increased ..." | ||
Vol 19, No 5 (2023) | Daily breakfast: will skipping a morning meal become a new prognostic marker? | Abstract similar documents |
O. B. Shvabskaia, N. S. Karamnova, O. M. Drapkina | ||
Vol 7, No 4 (2011) | FOCUS ON MAGNESIUM BASED DRUGS | Abstract similar documents |
I. I. Esenova | ||
"... этой целью рекомендовано назначение органических солей магния, имеющих ряд преимуществ. Целью данной ..." | ||
Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
M. M. Batiushin | ||
"... effect on the risk of developing and progressing CKD. Diet plays a certain preventive role. The main ..." | ||
Vol 4, No 4 (2008) | LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | Abstract similar documents |
A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov | ||
"... to hypolipidemic diet and standard therapy. Patients of the 2nd group (n=39) were treated with diet and standard ..." | ||
Vol 18, No 5 (2022) | A New Chapter in the Treatment of Patients with Heart Failure. The Role of Sodium-Glucose Co-transporter Type 2 Inhibitors | Abstract similar documents |
D. P. Golubovskaya, V. N. Karetnikova, I. R. Oleinik, O. L. Barbarash | ||
"... of the presence of disorders of carbohydrate metabolism. We are talking about inhibitors of the sodium-glucose co ..." | ||
Vol 20, No 2 (2024) | Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect | Abstract similar documents |
O N. Kurochkina, D. A. Korotkov, A. S. Sazhina, A N. Bogomolov | ||
"... In recent years, it has been shown that sodium-g lucose co-transporter type 2 inhibitors (SGLT2 ..." | ||
Vol 18, No 4 (2022) | Uric Acid as a Risk Factor for Cardiovascular Diseases | Abstract similar documents |
A. S. Safaryan, A. S. Lishuta, D. V. Nebieridze | ||
"... , attention is focused on the hypopurine diet, adequate drinking regimen and normalization of body weight ..." | ||
Vol 7, No 5 (2011) | DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES | Abstract similar documents |
N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina | ||
"... , a very small amount of trans fatty acid form. Such a fatty product is useful in antiatherogenic diets. ..." | ||
Vol 15, No 5 (2019) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) | Abstract similar documents |
A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya | ||
"... применение органических солей магния улучшило бы ситуацию в целом в связи с их универсальным множественным ..." | ||
Vol 18, No 4 (2022) | Refractory Arterial Hypertension: Features of Neurohormonal and Water-salt Imbalanceand Approaches to Antihypertensive Drug Therapy | Abstract similar documents |
O. B. Kuzmin, V. V. Zhezha | ||
"... , as well as renal sodium-glucose co-transporter type 2 inhibitors, which suppress the sympathetic nervous ..." | ||
Vol 3, No 5 (2007) | IDIOPATHIC SICK SINUS SYNDROME | Abstract similar documents |
S. Y. Nikulina, V. A. Schulman, A. A. Chernova | ||
Vol 20, No 3 (2024) | NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management | Abstract similar documents |
P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina | ||
"... with cardiovascular outcomes. New clinically relevant pleotorpic effects of statins, sodium-glucose cotransporter-2 ..." | ||
Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
"... after coronary artery bypass grafting (CABG), as well as to evaluate the effect of sodium-glucose ..." | ||
Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
"... + diet), group A2 (ACE inhibitor + fluvastatin), group B1 (angiotensin II receptor antagonist (ARA II ..." | ||
Vol 16, No 1 (2020) | The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion) | Abstract similar documents |
M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva | ||
"... for lipid-lowering therapy, and they are usually recommended a change in diet and supplementation ..." | ||
Vol 17, No 2 (2021) | Management of Patients with Chronic Heart Failure and Diabetes Mellitus | Abstract similar documents |
E. V. Reznik, T. L. Nguyen, G. N. Golukhov | ||
"... mellitus and in its presence. Recently, the effectiveness of type 2 sodium glucose cotransporter inhibitors ..." | ||
Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
"... of the diet (excessive consumption of table salt with food), low physical activity, chronic stress; both ..." | ||
Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
V. A. Sergeeva | ||
"... . Laboratory control of lipid metabolism remained inadequate. Insufficient lifestyle modification changes (diet ..." | ||
Vol 4, No 2 (2008) | EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY | Abstract similar documents |
A. V. Semenov, D. A. Sichev, V. G. Kukes | ||
"... of lipid-lowering diet. Atorvastatin (80 mg once daily in the first treatment day) was given to patients ..." | ||
Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
"... ), statins, sodium-glucose transporter type 2 inhibitors (SGLT-2i) and oral anticoagulants (OAC). Results ..." | ||
Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
O. M. Drapkina, O. E. Shirobokikh | ||
"... modulating of gut microbiota composition and function through diet, prebiotics, probiotics and fecal ..." | ||
Vol 17, No 5 (2021) | A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases | Abstract PDF (Eng) similar documents |
Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva | ||
"... and diet modification, and in the control group (n=60), patients were given only a standard brochure ..." | ||
Vol 1, No 3 (2005) | EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim | ||
"... with hyperlipidemia, who didn’t receive hypolipidemic drugs within 6 weeks, or followed hypolipidemic diet for 4 weeks ..." | ||
Vol 19, No 2 (2023) | Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease | Abstract similar documents |
E. D. Zharkova, Yu. V. Lukina, N. P. Kutishenko, E. T. Huseynova, N. P. Zolotareva, S. Yu. Martsevich, O. M. Drapkina | ||
"... habits (smoking), moderate physical activity, lowcholesterol and low-carb diet); (2) normalization ..." | ||
Vol 18, No 5 (2022) | The problem of obesity «through the eyes» of patients (results of the survey of patients of the outpatient registry) | Abstract similar documents |
O. V. Lerman, Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. M. Drapkina | ||
"... nutrition was revealed (insufficient amount of fruits and vegetables in the diet, salting food, eating ..." | ||
Vol 20, No 2 (2024) | Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? | Abstract similar documents |
D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash | ||
"... salt (p = 0.011), 1.3 times more likely to note the addition of dietary meat to the diet (p=0.003), 1 ..." | ||
Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
S. N. Tolpygina, S. Y. Martsevich | ||
"... patients kept the hypolipidaemic diet and did not receive any hypolipidaemic drug. 28 patients completed ..." | ||
Vol 8, No 1 (2012) | RANOLAZINE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
V. P. Lupanov | ||
"... Study results of a new anti-anginal drug (an inhibitor of sodium channels — ranolazine ..." | ||
Vol 18, No 6 (2022) | Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study | Abstract similar documents |
K. V. Charaya, D. Yu. Shchekochikhin, S. N. Tarasenko, N. A. Ananicheva, S. A. Sovetova, T. V. Soboleva, O. N. Dikur, A. I. Borenstein, D. A. Andreev | ||
"... Aim. To analyze the clinical significance of the sodium level in a single urine test obtained 2 ..." | ||
Vol 18, No 4 (2022) | N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials | Abstract similar documents |
E. M. Mezhonov, Yu. A. Vyalkina, S. V. Shalaev | ||
"... with the administration of saline solutions (sodium bicarbonate or sodium chloride 0.9%) or placebo. ..." | ||
Vol 6, No 3 (2010) | WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL? | Abstract similar documents |
E. V. Kuleshova | ||
"... Обсуждается связь различных солей метопролола (тартрата, сукцината и фумарата) и его лекарственных ..." | ||
Vol 10, No 6 (2014) | PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE | Abstract similar documents |
D. Yu. Shchekochikhin, Ph. Yu. Kopylov, N. L. Kozlovskaya, A. L. Syrkin | ||
"... with decompensated heart failure were analyzed. Hyponatremia was defined as serum sodium concentration of 135 mmol/l ..." | ||
Vol 6, No 2 (2010) | REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT | Abstract similar documents |
A. N. Britov, M. M. Bystrova | ||
"... употребление соли, алкоголя и прием некоторых лекарственных препаратов ухудшает контроль АД. У больных ..." | ||
Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... channels, increase the activity of Ca2+/Mg2+-ATPase and reduce the work of sodium channels. In animal ..." | ||
Vol 19, No 4 (2023) | Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy | Abstract similar documents |
S. R. Gilyarevsky, D. O. Ladygina | ||
"... concentration of aldosterone. The influence of the interaction between increased dietary sodium intake ..." | ||
Vol 20, No 3 (2024) | BRASH syndrome: а clinical case | Abstract similar documents |
D. D. Shalaeva, K. G. Pereverzeva, O. A. Fomina, S. S. Yakushin | ||
"... , 0.9% sodium chloride solution and furosemide were prescribed. The patient was discharged ..." | ||
Vol 13, No 3 (2017) | EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS | Abstract similar documents |
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina | ||
"... urinary sodium excretion, and BP level have been studied, as-well as soluble biomarkers: cyclic guanosine ..." | ||
Vol 16, No 4 (2020) | Sleep and Obesity: Mechanisms of Association | Abstract similar documents |
V. A. Dadaeva, A. A. Aleksandrov, A. S. Orlova, O. M. Drapkina | ||
"... – unhealthy diet and decreased physical exercise, specific attention should be given to the problems ..." | ||
Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
"... the missing nutrients in the diet and maintain health. In the course of the present review, an analysis ..." | ||
Vol 14, No 2 (2018) | NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY | Abstract similar documents |
S. G. Shulkina, Е. N. Smirnova | ||
"... (HT) and obesity treated with lisinopril and diet therapy. Material and methods. The study included ..." | ||
Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
"... dysfunction, carvedilol levels the imbalance of adipokine secretion, insulin resistance, sodium and water ..." | ||
Vol 1, No 3 (2005) | CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL | Abstract similar documents |
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina | ||
"... reabsorbtion, sodium clearance and excretion also increased in carvedilol group. After 12 month of treatment ..." | ||
Vol 14, No 4 (2018) | Main Approaches to Assessing the Quality of Drug Therapy in Cardiology | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, N. A. Komkova, N. A. Dmitrieva, O. A. Drapkina | ||
"... выбор лекарственной формы, соли препарата, оценка важных параметров безопасности и эффективности ..." | ||
Vol 19, No 6 (2023) | Endovenous laser ablation of great saphenous vein and pharmacotherapy of acute ascending thrombophlebitis: results of a three-month follow-up | Abstract similar documents |
K. A. Kaperiz, A. O. Rastatueva, I. S. Yavelov, O. M. Drapkina | ||
"... fondaparinux sodium therapy and endovenous laser ablation of the saphenofemoral junction in combination ..." | ||
Vol 21, No 1 (2025) | Physicians’ knowledge of therapy that affecting the prognosis of patients with chronic heart failure | Abstract similar documents |
N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
"... antagonist (MRA) + sodium- glucose cotransporter type 2 inhibitor (SGLT2i) was named as an optimal treatment ..." | ||
1 - 57 of 57 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)